Ranolazine (RANOLAZINE)

**Product type:** Human Prescription Drug

**Active ingredient:** RANOLAZINE

**Strength:** 500 mg/1

**Dosage form:** Tablet, Film Coated, Extended Release

**Route:** Oral

**Labeler:** Glenmark Pharmaceuticals Inc., USA

**Marketing category:** ANDA (ANDA211082)

**Pharmacologic class:** Anti-anginal [EPC], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]